Chun-Hou Liao Selected Research

Type A Botulinum Toxins (Botox)

12/2021	Effectiveness and Safety of Intradetrusor OnabotulinumtoxinA Injection for Neurogenic Detrusor Overactivity and Overactive Bladder Patients in Taiwan-A Phase IV Prospective, Interventional, Multiple-Center Study (Restore Study).
1/2019	Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
3/2016	Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Patients with Frailty, Medical Comorbidities or Prior Lower Urinary Tract Surgery.
12/2015	Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome.
11/2014	Diabetes mellitus does not affect the efficacy and safety of intravesical onabotulinumtoxinA injection in patients with refractory detrusor overactivity.
1/2014	Efficacy and safety of intravesical onabotulinumtoxinA injection on elderly patients with chronic central nervous system lesions and overactive bladder.
5/2013	Increased risk of large post-void residual urine and decreased long-term success rate after intravesical onabotulinumtoxinA injection for refractory idiopathic detrusor overactivity.
12/2010	Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chun-Hou Liao Research Topics

Disease

11	Overactive Urinary Bladder (Overactive Bladder) 12/2021 - 12/2010
7	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2019 - 12/2011
6	Lower Urinary Tract Symptoms 01/2019 - 09/2011
5	Erectile Dysfunction 01/2022 - 05/2015
5	Neoplasms (Cancer) 08/2021 - 01/2002
4	Inflammation (Inflammations) 06/2021 - 04/2012
3	Prostatic Neoplasms (Prostate Cancer) 08/2021 - 06/2011
3	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 06/2021 - 04/2011
3	Pelvic Pain 01/2020 - 09/2015
3	Urinary Incontinence 01/2020 - 12/2015
3	Wounds and Injuries (Trauma) 10/2011 - 01/2002
3	Hyperplasia 06/2011 - 11/2009
3	Pheochromocytoma 09/2008 - 08/2006
3	Pain (Aches) 09/2006 - 01/2002
2	Ganglion Cysts (Ganglion) 01/2022 - 01/2021
2	Ischemia 06/2021 - 01/2021
2	Renal Insufficiency (Renal Failure) 01/2021 - 08/2020
2	Fibrosis (Cirrhosis) 10/2020 - 08/2018
2	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2020 - 09/2015
2	Infections 01/2019 - 12/2011
2	Ureteral Calculi 01/2017 - 07/2013
2	Dementia (Dementias) 03/2016 - 01/2014
2	Stroke (Strokes) 03/2016 - 01/2014
2	Frailty 03/2016 - 05/2013
2	Parkinson Disease (Parkinson's Disease) 03/2016 - 01/2014
2	Urinary Retention 12/2015 - 01/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2012 - 03/2012
2	Carcinoma (Carcinomatosis) 04/2009 - 09/2008
2	Adenoma (Adenomas) 09/2008 - 09/2006
2	Convalescence 01/2005 - 01/2002
2	Postoperative Pain 01/2005 - 01/2002
1	Constipation 10/2022
1	Neoplasm Metastasis (Metastasis) 08/2021
1	Cystitis 06/2021
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 06/2021
1	Endotoxemia 01/2021
1	Proteinuria 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Heart Failure 10/2020
1	Chronic Renal Insufficiency 10/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2020
1	Sensation Disorders 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Prostatitis 01/2019
1	Neurogenic Inflammation 01/2019
1	Rupture 10/2018
1	False Aneurysm (Pseudoaneurysm) 10/2018
1	Urinary Tract Infections (Urinary Tract Infection) 01/2016
1	Paralysis (Palsy) 09/2015
1	Disease Progression 09/2015
1	Ataxia (Dyssynergia) 09/2015
1	Multiple Sclerosis 09/2015

Drug/Important Bio-Agent (IBA)

8	Type A Botulinum Toxins (Botox)FDA Link 12/2021 - 12/2010
5	incobotulinumtoxinA FDA Link 01/2020 - 09/2015
4	Muscarinic AntagonistsIBA 12/2015 - 05/2013
3	Therapeutic UsesIBA 06/2021 - 05/2015
3	Botulinum Toxins (Botulinum Toxin)IBA 01/2020 - 09/2015
3	mirabegronIBA 03/2019 - 11/2016
3	Gonadal Steroid Hormones (Sex Hormones)IBA 04/2012 - 09/2011
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2022 - 09/2017
2	Ketamine FDA LinkGeneric 06/2021 - 09/2017
2	IndicanIBA 10/2020 - 08/2020
2	C-Reactive ProteinIBA 04/2012 - 12/2011
2	Sex Hormone-Binding GlobulinIBA 04/2012 - 03/2012
2	Testosterone (Sustanon)FDA Link 03/2012 - 09/2011
2	AldosteroneIBA 09/2008 - 09/2006
2	Analgesics (Analgesic Drugs)IBA 01/2005 - 01/2002
2	Morphine (MS Contin)FDA LinkGeneric 01/2005 - 01/2002
1	Solifenacin Succinate FDA Link 10/2022
1	ChitosanIBA 01/2022
1	4-trifluoromethylsalicylic acid (HTB)IBA 08/2021
1	enzalutamideIBA 08/2021
1	norketamineIBA 06/2021
1	Cholinergic Agents (Cholinergics)IBA 06/2021
1	Nerve Growth Factor (NGF)IBA 06/2021
1	salicylhydroxamic acid (SHAM)IBA 06/2021
1	ChemokinesIBA 01/2021
1	Malondialdehyde (Propanedial)IBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	LigandsIBA 01/2021
1	Serine (L-Serine)FDA Link 01/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2020
1	Hormones (Hormone)IBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 09/2015
1	NeurotoxinsIBA 09/2015

Therapy/Procedure

6	Therapeutics 01/2018 - 01/2014
5	Adrenalectomy 09/2008 - 01/2002
3	Injections 01/2022 - 09/2015
3	Intravesical Administration 06/2021 - 12/2010
3	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 01/2016
3	Aftercare (After-Treatment) 07/2018 - 12/2015
3	Operative Time 09/2008 - 01/2002
2	Length of Stay 08/2006 - 01/2005
1	Castration 08/2021
1	Renal Dialysis (Hemodialysis) 10/2020
1	Transplantation 10/2018
1	Kidney Transplantation 10/2018
1	Nerve Crush 08/2018